Establishment and characterization of arsenic trioxide resistant KB/ATO cells

Arsenic trioxide (ATO) is used as a chemotherapeutic agent for the treatment of acute promyelocytic leukemia. However, increasing drug resistance is reducing its efficacy. Therefore, a better understanding of ATO resistance mechanism is required. In this study, we established an ATO-resistant human...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yun-Kai, Dai, Chunling, Yuan, Chun-gang, Wu, Hsiang-Chun, Xiao, Zhijie, Lei, Zi-Ning, Yang, Dong-Hua, Le, X. Chris, Fu, Liwu, Chen, Zhe-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595296/
https://www.ncbi.nlm.nih.gov/pubmed/28924550
http://dx.doi.org/10.1016/j.apsb.2017.04.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595296/
https://www.ncbi.nlm.nih.gov/pubmed/28924550
http://dx.doi.org/10.1016/j.apsb.2017.04.001

Ejemplares similares